Kekoa Taparra, MD, PhD(@KekoaMDPhD) 's Twitter Profile Photo

Embarrassed to say, but after 3 years of being safe, I finally got COVID for the first time. I honestly thought we were past this (society seems to have moved on) but clearly I was wrong.

Posting to bring awareness that we still need to at conferences ASTRO

Embarrassed to say, but after 3 years of being safe, I finally got COVID for the first time. I honestly thought we were past this (society seems to have moved on) but clearly I was wrong. 

Posting to bring awareness that we still need to #MaskUp at conferences #ASCO23 @ASTRO_org
account_circle
IMG Oncologists(@IMG_Oncologists) 's Twitter Profile Photo

🚨Excited to announce our FIRST IMG Oncologists Town Hall!!

Our 1st event after IMG CoP session at ✌🏻

We will be talking about future steps and introducing our subcommittees!
Everyone interested in volunteering/learning more are invited to join:
tinyurl.com/5bavjva2

🚨Excited to announce our FIRST IMG Oncologists Town Hall!!

Our 1st event after IMG CoP session at #ASCO23 ✌🏻

We will be talking about future steps and introducing our subcommittees!
Everyone interested in volunteering/learning more are invited to join:
tinyurl.com/5bavjva2
account_circle
Yakup Ergün(@dr_yakupergun) 's Twitter Profile Photo

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial | Journal of Clinical Oncology

Simple solutions to seemingly complex problems👇

Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial | Journal of Clinical Oncology

Simple solutions to seemingly complex problems👇

@JCO_ASCO #ASCO23  ascopubs.org/doi/10.1200/JC…
account_circle
Mark Lewis(@marklewismd) 's Twitter Profile Photo

Seems relevant to resurface Dr Andrew Ko’s observation at that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX ‼️

Seems relevant to resurface Dr Andrew Ko’s observation at #asco23 that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX ‼️
account_circle
AffyImmune Therapeutics(@affyimmune) 's Twitter Profile Photo

Live from New York, it's... AffyImmune!

Our friends at Ramp gave us a boost in Times Square, featuring a tweet by Center for Technology Licensing at Cornell about our clinical data from

Thanks to Ramp for the surprise and to our partners helping deliver AIC100 to patients in our clinical trial!

Live from New York, it's... AffyImmune! 

Our friends at @tryramp gave us a boost in Times Square, featuring a tweet by @Cornell_CTL about our clinical data from #ASCO23

Thanks to Ramp for the surprise and to our partners helping deliver AIC100 to patients in our clinical trial!
account_circle
MEDSIR(@wearemedsir) 's Twitter Profile Photo

Dr. Javier Cortes MD PhD presented the 3-year disease-free survival results at and, following The Lancet publication, emphasized the achievements attained in this study.

Learn more about the study: medsir.org/post/revolutio…

account_circle
Marlena(@MarlenaDM) 's Twitter Profile Photo

This picture from is very special to me, because the individuals in the picture are very special to me, therefore I had to post it separately. The best from Winship Cancer Institute of Emory University & the founders of GRASP Memories

This picture from #ASCO23 is very special to me, because the individuals in the picture are very special to me, therefore I had to post it separately. The best from @WinshipAtEmory & the founders of @GRASPtweets #ASCO23Memories
account_circle
Ivy Riano, M.D.(@IvyLorena_Md) 's Twitter Profile Photo

Thank you ASCO for featuring my photo in your Instagram feed!

I truly enjoyed connecting with students, residents and fellows at ASCOTECAG lounge

Thank you @ASCO for featuring my photo in your Instagram feed! 

I truly enjoyed connecting with students, residents and fellows at @ASCOTECAG lounge #ASCO23
account_circle
Anthony T. Nguyen, MD, PhD(@AnthonyNguyenMD) 's Twitter Profile Photo

Quick break from Cedars-Sinai Genitourinary Oncology Retreat to reflect on and thank ASTRO Chair Jeff Michalski for an incredibly Family-Friendly annual meeting!

Our daughters loved their “Future ASTRO Member” badges to match their ones!

Cancer at Cedars-Sinai Cedars-SinaiMed

Quick break from @CedarsSinai Genitourinary Oncology Retreat to reflect on #ASTRO23 and thank @ASTRO_Chair for an incredibly Family-Friendly annual meeting!

Our daughters loved their “Future @ASTRO_org Member” badges to match their #ASCO23 ones!

@CSCancerCenter @CedarsSinaiMed
account_circle
Mark Lewis(@marklewismd) 's Twitter Profile Photo

As it will clearly remain an issue at and beyond I'm remembering Anirban Maitra's admonition at that calculating PDL1 CPS scores is not as exact a science as we might like for a metric on which we are predicating major therapeutic choices for our patients

As it will clearly remain an issue at #GI24 and beyond I'm remembering @Aiims1742's admonition at #ASCO23 that calculating PDL1 CPS scores is not as exact a science as we might like for a metric on which we are predicating major therapeutic choices for our patients
account_circle
Nat #cancer_in_covid19#(@Nat71553043) 's Twitter Profile Photo

“Somos oncólogos y estamos aquí para curar pacientes” , aunq tu repaso de ASCO23 ha sido inmejorable (como siempre) xa mí esto es lo q +grande te hace# Congrats Javier Cortes MD PhD MamaCentro

“Somos oncólogos y estamos aquí para curar pacientes” , aunq tu repaso de ASCO23 ha sido inmejorable (como siempre) xa mí esto es lo q +grande te hace# Congrats @JavierCortesMD @MamaCentro
account_circle
CA: A Cancer Journal for Clinicians(@CACancerJournal) 's Twitter Profile Photo

Happy ! American Cancer Society (ACS) spoke with CA Editor Don S. Dizon MD (he/him) 🇬🇺 at on how far we've come in treating patients with cancer over the past 20 years.

Visit our collection of ACS Statistics to learn more about the progress being made:
acsjournals.onlinelibrary.wiley.com/doi/toc/10.332…

account_circle
GEICO-Spanish Gynaecological Cancer Research Group(@GEICOgroup) 's Twitter Profile Photo

Últimas conclusiones sobre y el tratamiento del en la XXII postASCO de tumores ginecológicos

Grandísima jornada 👏🏻👏🏻

GRACIAS 🙏🏻 ponentes, moderadores y coordinadores 💕

Últimas conclusiones sobre #ASCO23 y el tratamiento del #cancerdeovario en la XXII postASCO de tumores ginecológicos 

Grandísima jornada 👏🏻👏🏻

GRACIAS 🙏🏻 ponentes, moderadores y coordinadores 💕
account_circle
Eddie Cliff(@Eddie_Cliff) 's Twitter Profile Photo

Delighted to share our ASCO Education Book article: the High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions

We review the factors leading to the extremely high cost of CAR T-cells & propose potential solutions

🧵👇

ascopubs.org/doi/abs/10.120…

Delighted to share our @ASCO Education Book article: the High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions  

We review the factors leading to the extremely high cost of CAR T-cells & propose potential solutions

🧵👇

ascopubs.org/doi/abs/10.120…
#ASCO23
account_circle
Laurence Albiges(@AlbigesL) 's Twitter Profile Photo

Pleased to share The Lancet Oncology LENVA-PEMBRO across RCC variant histologies: papillary RCC, unclRCC and chromophobe RCC … interim ESMO - Eur. Oncology and final Chung-Han Lee 李宗翰, MD/PhD ASCO

full text: authors.elsevier.com/a/1hP1c5EIIgLp…
Thanks to all who change
rareRCC pts Tx!

Pleased to share @TheLancetOncol LENVA-PEMBRO  across RCC variant histologies: papillary RCC, unclRCC and chromophobe RCC … interim @myESMO #ESMO22 and  final @ChungHanLee3  @ASCO #ASCO23 

full text: authors.elsevier.com/a/1hP1c5EIIgLp… 
Thanks to all who change 
 rareRCC pts Tx!
account_circle